Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Sponsors » Advances in Spatial Genomics » Agilent, Mission Bio Ink Comarketing Agreement for Single-Cell Platform

Agilent, Mission Bio Ink Comarketing Agreement for Single-Cell Platform

Apr 23, 2020
|
staff reporter

NEW YORK – Mission Bio today announced a comarketing agreement for its Tapestri single-cell analysis platform with Agilent Technologies.

The deal will help bring Tapestri to cancer researchers in North America, Mission Bio said in a statement. The firms did not specify which Agilent products Tapestri will marketed together. 

Financial and other details of the agreement were not disclosed. Agilent has been investing in South San Francisco-based Mission Bio since 2014 and co-led the firm's 2018 $30 million Series B financing round.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Trump Announces Departure From WHO

President Donald Trump announced the US would be leaving the World Health Organization, NBC News reports.

Also, Vacuums Are Just Scary

A study of Great Danes homes in on a genomic region linked to fearfulness.

Limited Early Spread

CDC head says a new analysis indicates earlier testing wouldn't have caught viral spread, NPR reports.

PLOS Papers on Indonesian Archipelago Populations, Hookworm Secretome, Carotid Plaque GWAS

In PLOS this week: gene expression and epigenetics of Indonesian populations, hookworm parasite secretome, and more.

Jun
04
Featured Webinar

COVID-19 Testing, Treatment and Future Outlook

Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Jul
09
Featured Webinar

Our Magic DRAGEN: A Sequencing Lab Case Study on Accelerated Bioinformatics

Sponsored by
Illumina

In this webinar, Dr. Charlie Johnson, founder of the Texas A&M AgriLife Genomics and Bioinformatics Service, will share how his team is utilizing Illumina’s DRAGEN informatics platform in its high-throughput agrigenomics research program. 

Jul
15
Featured Webinar

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

What's Popular?

In Sequencing

  1. SARS-CoV-2 Result of Bat, Pangolin Virus Recombination, Purifying Selection, Study Suggests

  2. Germline Results From Tumor-Normal Sequencing Guides Precision Therapy in Advanced Cancer Patients

  3. Ginkgo Bioworks Nabs $70M Investment from Illumina, Others to Build Coronavirus NGS Testing

  4. Fry Laboratories Plans COVID-19 NGS Diagnostic Kit Offering

    Premium

  5. Metatranscriptomic Study of COVID-19 Patients Shows More Disrupted Airway Microbiome

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.